These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 15474280

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007.
    Meiers I, Shanks JH, Bostwick DG.
    Pathology; 2007 Jun; 39(3):299-304. PubMed ID: 17558856
    [Abstract] [Full Text] [Related]

  • 4. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma.
    Harden SV, Guo Z, Epstein JI, Sidransky D.
    J Urol; 2003 Mar; 169(3):1138-42. PubMed ID: 12576869
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.
    Cairns P, Esteller M, Herman JG, Schoenberg M, Jeronimo C, Sanchez-Cespedes M, Chow NH, Grasso M, Wu L, Westra WB, Sidransky D.
    Clin Cancer Res; 2001 Sep; 7(9):2727-30. PubMed ID: 11555585
    [Abstract] [Full Text] [Related]

  • 7. The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer.
    Woodson K, O'Reilly KJ, Hanson JC, Nelson D, Walk EL, Tangrea JA.
    J Urol; 2008 Feb; 179(2):508-11; discussion 511-2. PubMed ID: 18076912
    [Abstract] [Full Text] [Related]

  • 8. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.
    Nakayama M, Gonzalgo ML, Yegnasubramanian S, Lin X, De Marzo AM, Nelson WG.
    J Cell Biochem; 2004 Feb 15; 91(3):540-52. PubMed ID: 14755684
    [Abstract] [Full Text] [Related]

  • 9. Methylation-specific PCR for detection of neoplastic DNA in biopsy washings.
    Goessl C, Müller M, Heicappell R, Krause H, Schostak M, Straub B, Miller K.
    J Pathol; 2002 Mar 15; 196(3):331-4. PubMed ID: 11857497
    [Abstract] [Full Text] [Related]

  • 10. Hypermethylation of the CpG islands in the promoter region of the GSTP1 gene in prostate cancer: a useful diagnostic and prognostic marker?
    Bernardini S, Miano R, Iori R, Finazzi-Agrò E, Palmieri G, Ballerini S, Angeloni C, Orlandi A, Bellincampi L, Cortese C, Federici G.
    Clin Chim Acta; 2004 Dec 15; 350(1-2):181-8. PubMed ID: 15530476
    [Abstract] [Full Text] [Related]

  • 11. Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens.
    Gonzalgo ML, Pavlovich CP, Lee SM, Nelson WG.
    Clin Cancer Res; 2003 Jul 15; 9(7):2673-7. PubMed ID: 12855646
    [Abstract] [Full Text] [Related]

  • 12. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance.
    Reibenwein J, Pils D, Horak P, Tomicek B, Goldner G, Worel N, Elandt K, Krainer M.
    Prostate; 2007 Mar 01; 67(4):427-32. PubMed ID: 17192910
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer.
    Suh CI, Shanafelt T, May DJ, Shroyer KR, Bobak JB, Crawford ED, Miller GJ, Markham N, Glode LM.
    Mol Cell Probes; 2000 Aug 01; 14(4):211-7. PubMed ID: 10970725
    [Abstract] [Full Text] [Related]

  • 15. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO, Topaloglu O, Begum S, Henrique R, Rosenbaum E, Van Criekinge W, Westra WH, Sidransky D.
    J Clin Oncol; 2005 Sep 20; 23(27):6569-75. PubMed ID: 16170165
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hypermethylation of the CpG islands in the promoter region flanking GSTP1 gene is a potential plasma DNA biomarker for detecting prostate carcinoma.
    Chuang CK, Chu DC, Tzou RD, Liou SI, Chia JH, Sun CF.
    Cancer Detect Prev; 2007 Sep 20; 31(1):59-63. PubMed ID: 17291695
    [Abstract] [Full Text] [Related]

  • 19. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker.
    Lee WH, Isaacs WB, Bova GS, Nelson WG.
    Cancer Epidemiol Biomarkers Prev; 1997 Jun 20; 6(6):443-50. PubMed ID: 9184779
    [Abstract] [Full Text] [Related]

  • 20. Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results.
    Crocitto LE, Korns D, Kretzner L, Shevchuk T, Blair SL, Wilson TG, Ramin SA, Kawachi MH, Smith SS.
    Urology; 2004 Oct 20; 64(4):821-5. PubMed ID: 15491741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.